[Significance of the 19-S-IgM-FTA-ABS test in 30 TPHA-positive, clinically-undetected syphilis patients in evaluation of the need for therapy. A retrospective study].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000918:Antibody Specificity; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests / Q000379:methods*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis*; D012189:Retrospective Studies; D013587:Syphilis / Q000188:drug therapy* / Q000276:immunology; D013588:Syphilis Serodiagnosis / Q000379:methods*; D013591:Syphilis, Cutaneous / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Die Bedeutung des 19-S-IgM-FTA-ABS-Tests bei 30 TPHA-positiven, klinisch unauffälligen Syphilis-patienten in der Beurteilung der Therapiebedürftigkeit. Eine retrospektive Studie.